{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:17:41Z","timestamp":1785370661122,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05637-x","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T09:26:39Z","timestamp":1747733199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hydroxycitric acid inhibits ferroptosis and ameliorates benign prostatic hyperplasia by upregulating the Nrf2\/GPX4 pathway"],"prefix":"10.1007","volume":"43","author":[{"given":"Dayong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxi","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinran","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangsheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fachun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"3","key":"5637_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ajur.2017.06.004","volume":"4","author":"KB Lim","year":"2017","unstructured":"Lim KB (2017) Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol 4(3):148\u2013151. https:\/\/doi.org\/10.1016\/j.ajur.2017.06.004","journal-title":"Asian J Urol"},{"issue":"15","key":"5637_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.purol.2018.08.005","volume":"28","author":"G Robert","year":"2018","unstructured":"Robert G, De La Taille A, Descazeaud A (2018) Epidemiology of benign prostatic hyperplasia. Prog Urol 28(15):803\u2013812. https:\/\/doi.org\/10.1016\/j.purol.2018.08.005","journal-title":"Prog Urol"},{"issue":"12","key":"5637_CR3","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1007\/s00345-023-04658-8","volume":"41","author":"D Liu","year":"2023","unstructured":"Liu D, Li C, Li Y et al (2023) Benign prostatic hyperplasia burden comparison between China and United States based on the global burden of disease study 2019. World J Urol 41(12):3629\u20133634. https:\/\/doi.org\/10.1007\/s00345-023-04658-8","journal-title":"World J Urol"},{"issue":"7","key":"5637_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/pros.24114","volume":"81","author":"A Tamalunas","year":"2021","unstructured":"Tamalunas A, Sauckel C, Ciotkowska A et al (2021) Inhibition of human prostate stromal cell growth and smooth muscle contraction by thalidomide: a novel remedy in LUTS? Prostate 81(7):377\u2013389. https:\/\/doi.org\/10.1002\/pros.24114","journal-title":"Prostate"},{"issue":"03","key":"5637_CR5","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.12677\/acm.2023.133603","volume":"13","author":"L Lian","year":"2023","unstructured":"Lian L, Gj C (2023) Benign prostatic hyperplasia and lower urinary tract symptoms. Acm 13(03):4208\u20134214. https:\/\/doi.org\/10.12677\/acm.2023.133603","journal-title":"Acm"},{"issue":"4","key":"5637_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/path.5857","volume":"256","author":"DB Joseph","year":"2022","unstructured":"Joseph DB, Henry GH, Malewska A et al (2022) 5-Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia. J Pathol 256(4):427\u2013441. https:\/\/doi.org\/10.1002\/path.5857","journal-title":"J Pathol"},{"issue":"2","key":"5637_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1210\/en.2006-0906","volume":"148","author":"SJ McPherson","year":"2007","unstructured":"McPherson SJ, Ellem SJ, Simpson ER, Patchev V, Fritzemeier KH, Risbridger GP (2007) Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology 148(2):566\u2013574. https:\/\/doi.org\/10.1210\/en.2006-0906","journal-title":"Endocrinology"},{"issue":"10","key":"5637_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41585-021-00496-8","volume":"18","author":"G Fiard","year":"2021","unstructured":"Fiard G, Stavrinides V, Chambers ES et al (2021) Cellular senescence as a possible link between prostate diseases of the ageing male. Nat Rev Urol 18(10):597\u2013610. https:\/\/doi.org\/10.1038\/s41585-021-00496-8","journal-title":"Nat Rev Urol"},{"issue":"1","key":"5637_CR9","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/s41467-022-29719-1","volume":"13","author":"RE Vickman","year":"2022","unstructured":"Vickman RE, Aaron-Brooks L, Zhang R et al (2022) TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease. Nat Commun 13(1):2133\u20132140. https:\/\/doi.org\/10.1038\/s41467-022-29719-1","journal-title":"Nat Commun"},{"issue":"1","key":"5637_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13046-016-0418-8","volume":"35","author":"UK Udensi","year":"2016","unstructured":"Udensi UK, Tchounwou PB (2016) Oxidative stress in prostate hyperplasia and carcinogenesis. J Exp Clin Cancer Res 35(1):139\u2013146. https:\/\/doi.org\/10.1186\/s13046-016-0418-8","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"5637_CR11","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1080\/07853890.2023.2197293","volume":"55","author":"MC Suarez Arbelaez","year":"2023","unstructured":"Suarez Arbelaez MC, Nackeeran S, Shah K et al (2023) Association between body mass index, metabolic syndrome and common urologic conditions: a cross-sectional study using a large multi-institutional database from the United States. Ann med 55(1):2197\u20132003. https:\/\/doi.org\/10.1080\/07853890.2023.2197293","journal-title":"Ann med"},{"issue":"14","key":"5637_CR12","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1080\/14656566.2023.2237406","volume":"24","author":"A Koudonas","year":"2023","unstructured":"Koudonas A, Anastasiadis A, Tsiakaras S et al (2023) Overview of current pharmacotherapeutic options in benign prostatic hyperplasia. Expert Opin Pharmaco 24(14):1609\u20131622. https:\/\/doi.org\/10.1080\/14656566.2023.2237406","journal-title":"Expert Opin Pharmaco"},{"issue":"4","key":"5637_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/13543784.2024.2326023","volume":"33","author":"S Katsimperis","year":"2024","unstructured":"Katsimperis S, Kapriniotis K, Manolitsis I et al (2024) Early investigational agents for the treatment of benign prostatic hyperplasia\u2019. Expert Opin Inv Drug 33(4):359\u2013370. https:\/\/doi.org\/10.1080\/13543784.2024.2326023","journal-title":"Expert Opin Inv Drug"},{"issue":"11","key":"5637_CR14","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/j.1742-1241.2012.03010.x","volume":"66","author":"SA Kaplan","year":"2012","unstructured":"Kaplan SA, Chung DE, Lee RK, Scofield S, Te AE (2012) A 5-year retrospective analysis of 5\u03b1-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride. Int J Clin Pract 66(11):1052\u20131055. https:\/\/doi.org\/10.1111\/j.1742-1241.2012.03010.x","journal-title":"Int J Clin Pract"},{"issue":"3","key":"5637_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/1557988314538445","volume":"9","author":"CA Ganzer","year":"2015","unstructured":"Ganzer CA, Jacobs AR, Iqbal F (2015) Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms. Am j mens health 9(3):222\u2013228. https:\/\/doi.org\/10.1177\/1557988314538445","journal-title":"Am j mens health"},{"issue":"1","key":"5637_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.sexol.2021.07.002","volume":"31","author":"R Sugianto","year":"2022","unstructured":"Sugianto R, Tirtayasa P, Duarsa G (2022) A comprehensive review of medical therapy on benign prostatic hyperplasia. Sexologies 31(1):52\u201360. https:\/\/doi.org\/10.1016\/j.sexol.2021.07.002","journal-title":"Sexologies"},{"issue":"5","key":"5637_CR17","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"issue":"2","key":"5637_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H et al (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171(2):273\u2013285. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021","journal-title":"Cell"},{"issue":"16","key":"5637_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q (2013) Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol 53(16):401\u2013426. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011112-140320","journal-title":"Annu Rev Pharmacol"},{"issue":"1\u20132","key":"5637_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156(1\u20132):317\u2013331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010","journal-title":"Cell"},{"issue":"21","key":"5637_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD (2019) NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol 23(21):1011\u20131018. https:\/\/doi.org\/10.1016\/j.redox.2019.101107","journal-title":"Redox Biol"},{"issue":"5","key":"5637_CR22","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1016\/j.bbagen.2012.11.020","volume":"1830","author":"R Brigelius-Floh\u00e9","year":"2013","unstructured":"Brigelius-Floh\u00e9 R, Maiorino M (2013) Glutathione peroxidases. Biochim Biophys Acta 1830(5):3289\u20133303. https:\/\/doi.org\/10.1016\/j.bbagen.2012.11.020","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"5637_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/cns.13657","volume":"36","author":"MH Ge","year":"2021","unstructured":"Ge MH, Tian H, Mao L et al (2021) Zinc attenuates ferroptosis and promotes functional recovery in contusion spinal cord injury by activating Nrf2\/GPX4 defense pathway. CNS Neurosci Ther 36(8):156\u2013163. https:\/\/doi.org\/10.1111\/cns.13657","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"5637_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"G Lei","year":"2020","unstructured":"Lei G, Zhang Y, Koppula P et al (2020) The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell res 30(2):146\u2013162. https:\/\/doi.org\/10.1038\/s41422-019-0263-3","journal-title":"Cell res"},{"issue":"5","key":"5637_CR25","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/jnc.15519","volume":"159","author":"M Jakaria","year":"2021","unstructured":"Jakaria M, Belaidi AA, Bush AI, Ayton S (2021) Ferroptosis as a mechanism of neurodegeneration in Alzheimer\u2019s disease. J Neurochem 159(5):804\u2013825. https:\/\/doi.org\/10.1111\/jnc.15519","journal-title":"J Neurochem"},{"issue":"4","key":"5637_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.molmed.2022.02.003","volume":"28","author":"ZL Wang","year":"2022","unstructured":"Wang ZL, Yuan L, Li W, Li JY (2022) Ferroptosis in Parkinson\u2019s disease: glia-neuron crosstalk. Trends Mol Med 28(4):258\u2013269. https:\/\/doi.org\/10.1016\/j.molmed.2022.02.003","journal-title":"Trends Mol Med"},{"issue":"10","key":"5637_CR27","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCRESAHA.123.323517","volume":"133","author":"G Ichihara","year":"2023","unstructured":"Ichihara G, Katsumata Y, Sugiura Y et al (2023) MRP1-dependent extracellular release of glutathione induces cardiomyocyte ferroptosis after ischemia-reperfusion. Circ res 133(10):861\u2013876. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.323517","journal-title":"Circ res"},{"issue":"1","key":"5637_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41392-022-00917-z","volume":"7","author":"QZ Tuo","year":"2022","unstructured":"Tuo QZ, Liu Y, Xiang Z et al (2022) Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia\/reperfusion. Signal Transduct Tar 7(1):51\u201359. https:\/\/doi.org\/10.1038\/s41392-022-00917-z","journal-title":"Signal Transduct Tar"},{"issue":"1","key":"5637_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12967-023-04432-9","volume":"21","author":"Y Li","year":"2023","unstructured":"Li Y, Zhou Y, Liu D et al (2023) Glutathione peroxidase 3 induced mitochondria-mediated apoptosis via AMPK \/ERK1\/2 pathway and resisted autophagy-related ferroptosis via AMPK\/mTOR pathway in hyperplastic prostate. J Transl Med 21(1):575\u2013583. https:\/\/doi.org\/10.1186\/s12967-023-04432-9","journal-title":"J Transl Med"},{"issue":"5","key":"5637_CR30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.gendis.2023.101184","volume":"11","author":"L Zhou","year":"2024","unstructured":"Zhou L, Li Y, Li J et al (2024) Multi-omics analysis to identify CBR3-AS1-hsa-miR-145-5p-MAP3K5 pathway as a ferroptosis-related ceRNA network in benign prostatic hyperplasia. Genes Dis 11(5):1011\u201310149. https:\/\/doi.org\/10.1016\/j.gendis.2023.101184","journal-title":"Genes Dis"},{"issue":"13","key":"5637_CR31","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.redox.2024.103298","volume":"75","author":"M Zhan","year":"2024","unstructured":"Zhan M, Xu H, Yu G et al (2024) Androgen receptor deficiency-induced TUG1 in suppressing ferroptosis to promote benign prostatic hyperplasia through the miR-188-3p\/GPX4 signal pathway. Redox Biol 75(13):1032\u20131039. https:\/\/doi.org\/10.1016\/j.redox.2024.103298","journal-title":"Redox Biol"},{"issue":"24","key":"5637_CR32","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.prp.2022.154211","volume":"240","author":"A Ismail","year":"2022","unstructured":"Ismail A, Mokhlis HA, Sharaky M et al (2022) Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase. Pathol Res Pract 240(24):1542\u20131548. https:\/\/doi.org\/10.1016\/j.prp.2022.154211","journal-title":"Pathol Res Pract"},{"issue":"10","key":"5637_CR33","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.4103\/1673-5374.193240","volume":"11","author":"M Goudarzvand","year":"2016","unstructured":"Goudarzvand M, Afraei S, Yaslianifard S et al (2016) Hydroxycitric acid ameliorates inflammation and oxidative stress in mouse models of multiple sclerosis. Neural regen res 11(10):1610\u20131616. https:\/\/doi.org\/10.4103\/1673-5374.193240","journal-title":"Neural regen res"},{"issue":"36","key":"5637_CR34","doi-asserted-by":"publisher","first-page":"196","DOI":"10.29219\/fnr.v67.8977","volume":"67","author":"J Dong","year":"2023","unstructured":"Dong J, Li W, Du X et al (2023) Garcinia cambogia water extract alleviates insulin resistance and hepatic lipid accumulation in mice fed a high-fat diet. Food Nutr Res 67(36):196\u2013205. https:\/\/doi.org\/10.29219\/fnr.v67.8977","journal-title":"Food Nutr Res"},{"issue":"12","key":"5637_CR35","doi-asserted-by":"publisher","first-page":"9868","DOI":"10.3390\/cimb45120616","volume":"45","author":"ZL Lu","year":"2023","unstructured":"Lu ZL, Song CK, Zou SS et al (2023) Hydroxycitric acid alleviated lung ischemia-reperfusion injury by inhibiting oxidative stress and ferroptosis through the Hif-1\u03b1 pathway. Curr Issues Mol Biol 45(12):9868\u20139886. https:\/\/doi.org\/10.3390\/cimb45120616","journal-title":"Curr Issues Mol Biol"},{"issue":"2","key":"5637_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7(2):27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703","journal-title":"J Basic Clin Pharm"},{"key":"5637_CR37","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1155\/2012\/197920","volume":"36","author":"LO Chuah","year":"2012","unstructured":"Chuah LO, Yeap SK, Ho WY, Beh BK (2012) Alitheen NB (2012) In vitro and in vivo toxicity of garcinia or hydroxycitric acid: a review. Evid-Based Compl Alt 36:1979\u20131985. https:\/\/doi.org\/10.1155\/2012\/197920","journal-title":"Evid-Based Compl Alt"},{"issue":"2","key":"5637_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL et al (2020) Ferroptosis: past, present and future. Cell Death Dis 11(2):88\u201398. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","journal-title":"Cell Death Dis"},{"issue":"1","key":"5637_CR39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1021\/jf010753k","volume":"50","author":"BS Jena","year":"2002","unstructured":"Jena BS, Jayaprakasha GK, Singh RP, Sakariah KK (2002) Chemistry and biochemistry of (-)-hydroxycitric acid from Garcinia. J Agr Food Chem 50(1):10\u201322. https:\/\/doi.org\/10.1021\/jf010753k","journal-title":"J Agr Food Chem"},{"issue":"45","key":"5637_CR40","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.chemosphere.2023.139716","volume":"339","author":"J Shi","year":"2023","unstructured":"Shi J, Ma C, Zheng Z et al (2023) Low-dose antimony exposure promotes prostate cancer proliferation by inhibiting ferroptosis via activation of the Nrf2-SLC7A11-GPX4 pathway. Chemosphere 339(45):1397\u20131442. https:\/\/doi.org\/10.1016\/j.chemosphere.2023.139716","journal-title":"Chemosphere"},{"issue":"8","key":"5637_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/antiox10081226","volume":"10","author":"JH Han","year":"2021","unstructured":"Han JH, Park MH, Myung CS (2021) Garcinia cambogia ameliorates non-alcoholic fatty liver disease by inhibiting oxidative stress-mediated steatosis and apoptosis through NRF2-ARE activation. Antioxidants (Basel) 10(8):59\u201365. https:\/\/doi.org\/10.3390\/antiox10081226","journal-title":"Antioxidants (Basel)"},{"issue":"11","key":"5637_CR42","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S2666-7568(22)00213-6","volume":"3","author":"FA Awedew","year":"2022","unstructured":"Awedew FA, Han H, Abbasi B, et al (2022) The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the global burden of disease study 2019. Lancet Healthy Longev 3(11):754\u2013776. https:\/\/doi.org\/10.1016\/S2666-7568(22)00213-6","journal-title":"Lancet Healthy Longev"},{"issue":"4","key":"5637_CR43","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.juro.2006.11.065","volume":"177","author":"AR Kristal","year":"2007","unstructured":"Kristal AR, Arnold KB, Schenk JM et al (2007) Race\/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urology 177(4):1395\u20131400. https:\/\/doi.org\/10.1016\/j.juro.2006.11.065","journal-title":"J Urology"},{"issue":"4","key":"5637_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/15579883211036786","volume":"15","author":"XF Xu","year":"2021","unstructured":"Xu XF, Liu GX, Guo YS et al (2021) Global, regional, and national incidence and year lived with disability for benign prostatic hyperplasia from 1990 to 2019. Am J Mens Health 15(4):155\u2013161. https:\/\/doi.org\/10.1177\/15579883211036786","journal-title":"Am J Mens Health"},{"issue":"22","key":"5637_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-3-642-16499-6_4","volume":"42","author":"JP Hieble","year":"2011","unstructured":"Hieble JP (2011) Animal models for benign prostatic hyperplasia. Handb Exp Pharmacol 42(22):69\u201379. https:\/\/doi.org\/10.1007\/978-3-642-16499-6_4","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"5637_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41391-020-00277-1","volume":"24","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhang M, Tang J et al (2021) Animal models of benign prostatic hyperplasia. Prostate Cancer 24(1):49\u201357. https:\/\/doi.org\/10.1038\/s41391-020-00277-1","journal-title":"Prostate Cancer"},{"issue":"1","key":"5637_CR47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/sj.pcan.4500391","volume":"3","author":"W Mahapokai","year":"2000","unstructured":"Mahapokai W, Van Sluijs FJ, Schalken JA (2000) Models for studying benign prostatic hyperplasia. Prostate Cancer 3(1):28\u201333. https:\/\/doi.org\/10.1038\/sj.pcan.4500391","journal-title":"Prostate Cancer"},{"issue":"9","key":"5637_CR48","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41417-020-0170-2","volume":"27","author":"C Dai","year":"2020","unstructured":"Dai C, Chen X, Li J, Comish P, Kang R, Tang D (2020) Transcription factors in ferroptotic cell death. Cancer Gene Ther 27(9):645\u2013656. https:\/\/doi.org\/10.1038\/s41417-020-0170-2","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"5637_CR49","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1172\/JCI88574","volume":"127","author":"X Yang","year":"2017","unstructured":"Yang X, Park SH, Chang HC et al (2017) Sirtuin 2 regulates cellular iron homeostasis via deacetylation of transcription factor NRF2. J Clin Invest 127(4):1505\u20131516. https:\/\/doi.org\/10.1172\/JCI88574","journal-title":"J Clin Invest"},{"issue":"17","key":"5637_CR50","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1089\/ars.2017.7176","volume":"29","author":"MJ Kerins","year":"2018","unstructured":"Kerins MJ, Ooi A (2018) The roles of NRF2 in modulating cellular iron homeostasis. Antioxid Redox Sign 29(17):1756\u20131773. https:\/\/doi.org\/10.1089\/ars.2017.7176","journal-title":"Antioxid Redox Sign"},{"issue":"53","key":"5637_CR51","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.scitotenv.2022.160839","volume":"86","author":"J Liu","year":"2023","unstructured":"Liu J, Yang G, Zhang H (2023) Glyphosate-triggered hepatocyte ferroptosis via suppressing Nrf2\/GSH\/GPX4 axis exacerbates hepatotoxicity. Sci Total Environ 86(53):1608\u20131614. https:\/\/doi.org\/10.1016\/j.scitotenv.2022.160839","journal-title":"Sci Total Environ"},{"issue":"22","key":"5637_CR52","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt TM, Proneth B, Conrad M (2019) Role of GPX4 in ferroptosis and its pharmacological implication. Free Radical Bio Med 133(22):144\u2013152. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.09.014","journal-title":"Free Radical Bio Med"},{"issue":"3","key":"5637_CR53","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/s0367-326x(03)00036-4","volume":"74","author":"K Hayamizu","year":"2003","unstructured":"Hayamizu K, Hirakawa H, Oikawa D et al (2003) Effect of Garcinia cambogia extract on serum leptin and insulin in mice. Fitoterapia 74(3):267\u2013273. https:\/\/doi.org\/10.1016\/s0367-326x(03)00036-4","journal-title":"Fitoterapia"},{"issue":"62","key":"5637_CR54","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.fitote.2015.02.012","volume":"102","author":"RB Semwal","year":"2015","unstructured":"Semwal RB, Semwal DK, Vermaak I, Viljoen A (2015) A comprehensive scientific overview of Garcinia cambogia. Fitoterapia 102(62):134\u2013148. https:\/\/doi.org\/10.1016\/j.fitote.2015.02.012","journal-title":"Fitoterapia"},{"issue":"1","key":"5637_CR55","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.28251","volume":"63","author":"X Sun","year":"2016","unstructured":"Sun X, Ou Z, Chen R et al (2016) Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63(1):173\u2013184. https:\/\/doi.org\/10.1002\/hep.28251","journal-title":"Hepatology"},{"issue":"25","key":"5637_CR56","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","volume":"59","author":"M Dodson","year":"2019","unstructured":"Dodson M, de la Vega MR, Cholanians AB, Schmidlin CJ, Chapman E, Zhang DD (2019) Modulating NRF2 in disease: timing is everything. Annu Rev Pharmacol 59(25):555\u2013575. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010818-021856","journal-title":"Annu Rev Pharmacol"},{"issue":"6","key":"5637_CR57","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1007\/s10565-023-09834-5","volume":"39","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhang L, Yao G, Zhao H, Wu S (2023) NRF2 is essential for iron-overload stimulated osteoclast differentiation through regulation of redox and iron homeostasis. Cell biol toxicol 39(6):3305\u20133321. https:\/\/doi.org\/10.1007\/s10565-023-09834-5","journal-title":"Cell biol toxicol"},{"issue":"63","key":"5637_CR58","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jep.2025.119335","volume":"341","author":"X Meng","year":"2025","unstructured":"Meng X, Zhao W, Yang R et al (2025) Lignans from Schisandra chinensis (Turcz) Baill ameliorates cognitive impairment in Alzheimer\u2019s disease and alleviates ferroptosis by activating the Nrf2\/FPN1 signaling pathway and regulating iron levels. J ethnopharmacol 341(63):1193\u20131199. https:\/\/doi.org\/10.1016\/j.jep.2025.119335","journal-title":"J ethnopharmacol"},{"issue":"12","key":"5637_CR59","doi-asserted-by":"publisher","first-page":"663","DOI":"10.5650\/jos.52.663","volume":"52","author":"Y Ishii","year":"2003","unstructured":"Ishii Y, Kaneko I, Shen M et al (2003) Safety of Garcinia cambogia extract in healthy volunteers: high-dose administration study II. J Oleo Sci 52(12):663\u2013671. https:\/\/doi.org\/10.5650\/jos.52.663","journal-title":"J Oleo Sci"},{"issue":"4","key":"5637_CR60","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.fitote.2007.12.003","volume":"79","author":"K Hayamizu","year":"2008","unstructured":"Hayamizu K, Tomi H, Kaneko I, Shen M, Soni MG, Yoshino G (2008) Effects of Garcinia cambogia extract on serum sex hormones in overweight subjects. Fitoterapia 79(4):255\u2013261. https:\/\/doi.org\/10.1016\/j.fitote.2007.12.003","journal-title":"Fitoterapia"},{"issue":"5","key":"5637_CR61","doi-asserted-by":"publisher","first-page":"365","DOI":"10.5650\/jos.51.365","volume":"51","author":"K Hayamizu","year":"2002","unstructured":"Hayamizu K, Ishii Y, Kaneko I et al (2002) No-observed-adverse-effect level (NOAEL) and sequential-high-doses administration study on Garcinia cambogia extract in humans. J oleo sci 51(5):365\u2013369. https:\/\/doi.org\/10.5650\/jos.51.365","journal-title":"J oleo sci"}],"updated-by":[{"DOI":"10.1007\/s00345-025-05971-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000}}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05637-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05637-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05637-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:54:00Z","timestamp":1767966840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05637-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5637"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05637-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5422680\/v1","asserted-by":"object"}]},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00345-025-05971-0","URL":"https:\/\/doi.org\/10.1007\/s00345-025-05971-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experimental procedures were conducted in accordance with the \"Guide for the Care and Use of Laboratory Animals\" by the National Institutes of Health, following formal approval from the Animal Ethics Review Committee of Kunming Medical University. The ethics committee approval number for this study is kmmu20240132.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"318"}}